About Us
Corporate overview
Our History & Milestones
Our Purpose
Our Leadership Team
Research & Development
ESG Footprint
— Overview
— Environment
— Social
— Corporate Governance
— Policies & Disclosures
Our ESG Footprint: ‘Caring for Society’
Learn More
Our History: ‘built on a foundation of strong values.
Learn More
Businesses
Business overview
Active Pharma Ingredients (API)
— Regulatory
Specialty Chemicals
API: ‘discover our API & Bulk Drugs Portfolio’
Learn More
Chemicals: ‘serving India through our Speciality Chemicals’
Learn More
Manufacturing
Manufacturing Capability
Accreditations
IBU Derivative: ‘going up the value chain’
Learn More
Ethyl Acetate: ‘Fostering Green Chemistry’
Learn More
Investors
Overview
Annual Reports
Annual Returns
Sustainability Report
Greenhouse Gas Emissions Report
Financial Performance
Subsidiaries Financial Statements
Shareholding Pattern
Governance Reports
Press Releases & News Publications
Shareholders Meetings AGM/EGM/Postal Ballot
Investors Education Protection Funds / Unclaimed Dividend
Corporate Policies
Corporate Benefits
Investor Services
Email Registration Form
KYC & Nomination Forms
Stock Information
Board of Directors
Governance Structure
Disclosure under Regulation
46
INVESTOR ZONE
— Investor Events
— Investor Resources
— Earnings Concall
— Analyst Speak
ESG Footprint
— Overview
— Environment
— Social
— Corporate Governance
— Policies & Disclosures
Media
Media Coverage
Press Releases & News Publications
Media Coverage
Learn More
Press Releases & News Publications
Learn More
Careers
Get In Touch
Analyst Speak and Research Reports
Home
Investors
Analyst Speak
IOL Chemicals and Pharmaceuticals Limited is covered by brokerage houses on an ongoing basis. To know more about the latest analysts and research reports, we invite you to engage with our Investor Relations team.
For more details, please contact us
+91-161-2225531-35 or write to us at
investor@iolcp.com
ENGAGE WITH OUR TEAM NOW